Ovasitol® Inositol
Patented Ingredients
Inositol
Ingredient Overview
A patented myo-inositol formula launched by the American company Theralogix is a 40:1 compound ratio of myo-inositol and D-chiro-inositol.
Key Advantages
- Patented 40:1 myo-inositol/D-chiral myo-inositol compound ratio, simulating the physiological ratio of human plasma
- Multiple clinical trials have proven that it can improve ovulation function and insulin resistance in PCOS patients.
- Obtained US FDA GRAS certification and multiple international patents
- Designated inositol ingredient for many gynecological and reproductive health brands around the world
Talk With Tinus
Contact us for formulation direction, dosage form planning, or sampling support.
Back to Custom Formulation